| |
| |
|
| Insider
Information: |
Bodick Neil |
| Relationship: |
Chief Scientific Officer |
| City: |
Burlington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
100,153 |
|
|
Indirect Shares
|
389,683 |
|
|
| Direct
Value |
$913,395 |
|
|
|
Indirect Value
|
$3,553,909 |
|
|
| Total
Shares |
489,836 |
|
|
| Total
Value |
$4,467,304 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -48.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Flexion Therapeutics Inc |
FLXN |
Chief Scientific Officer |
2020-01-03 |
100,153 |
2020-01-03 |
389,683 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
• – – |
2020-01-03 |
4 |
S |
$0.00 |
$0 |
D/D |
(3,851) |
100,153 |
0 |
% |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
• – – |
2019-10-07 |
4 |
D |
$13.98 |
$18,817 |
D/D |
(1,346) |
104,004 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
• – – |
2019-10-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,568 |
105,350 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
100,782 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
• – – |
2019-01-03 |
4 |
AS |
$12.36 |
$9,221 |
D/D |
(746) |
64,782 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
• – – |
2018-10-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,566 |
66,873 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
• – – |
2018-10-08 |
4 |
D |
$18.60 |
$25,017 |
D/D |
(1,345) |
65,528 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
• – – |
2018-07-03 |
4 |
AS |
$25.00 |
$412,300 |
D/D |
(16,492) |
62,307 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
• – – |
2018-07-02 |
4 |
AS |
$25.10 |
$841,192 |
D/D |
(33,508) |
78,799 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
• – – |
2018-05-11 |
4 |
OE |
$0.16 |
$6,130 |
D/D |
37,702 |
112,307 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
• – – |
2018-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
74,605 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-11-21 |
4 |
B |
$24.66 |
$24,656 |
I/I |
1,000 |
1,000 |
1.99 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-11-21 |
4 |
B |
$24.39 |
$41,457 |
D/D |
1,700 |
64,605 |
2.74 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-10-06 |
4 |
D |
$29.93 |
$47,835 |
D/D |
(1,598) |
62,905 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-10-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,566 |
64,503 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
• – – |
2017-05-15 |
4/A |
OE |
$2.52 |
$17,214 |
D/D |
6,830 |
66,767 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
• – – |
2017-05-15 |
4/A |
AS |
$18.81 |
$129,448 |
D/D |
(6,830) |
59,937 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
• – – |
2017-05-15 |
4 |
AS |
$18.81 |
$129,448 |
D/D |
(6,830) |
39,107 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
• – – |
2017-04-17 |
4 |
AS |
$28.20 |
$141,132 |
D/D |
(5,000) |
45,937 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
• – – |
2017-04-17 |
4/A |
AS |
$28.20 |
$141,132 |
D/D |
(5,000) |
59,937 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
• – – |
2017-04-17 |
4/A |
OE |
$2.52 |
$12,602 |
D/D |
5,000 |
64,937 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
• – – |
2017-03-17 |
4/A |
AS |
$20.41 |
$102,038 |
D/D |
(5,000) |
59,937 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
• – – |
2017-03-17 |
4/A |
OE |
$2.52 |
$12,602 |
D/D |
5,000 |
64,937 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
• – – |
2017-03-17 |
4 |
AS |
$20.41 |
$102,038 |
D/D |
(5,000) |
50,937 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Medical Officer |
• – – |
2017-02-24 |
4/A |
AS |
$19.15 |
$95,758 |
D/D |
(5,000) |
59,937 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
